Biophytis S.A.
BPTS · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.03 | 0.04 | -0.03 |
| FCF Yield | -0.02% | -0.01% | -0.01% | -0.01% |
| EV / EBITDA | -7.58 | -6.28 | -11.31 | -6.26 |
| Quality | ||||
| ROIC | -124.89% | -169.98% | -67.54% | -88.32% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.02 | 0.51 | 1.05 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -23.16% | 41.34% | 6.69% | -71.98% |
| Safety | ||||
| Net Debt / EBITDA | -1.76 | -0.37 | -0.59 | -0.10 |
| Interest Coverage | 0.00 | -7.95 | -4.29 | -26.90 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 1.97 | 0.42 |
| Cash Conversion Cycle | 0.00 | -371.58 | -1,067.70 | -722.96 |